Unveiling the Mechanisms for Decreased Glutathione in Individuals with HIV Infection
Figure 2
(a) Assay of TGF-β in plasma from HIV-infected and healthy subjects. Plasma samples separated from blood of healthy volunteers and HIV-infected individuals were used for measurement of TGF-β. Levels of TGF-β in the plasma samples were determined by ELISA using assay kits procured from eBioscience. Results in Figure 2 are averages of data collected from eight healthy subjects and twelve individuals with HIV infection. Results show elevated TGF-β in HIV-infected subjects (*). (b) Assay of IL-1 in plasma from HIV-infected and healthy subjects. Plasma samples separated from blood of healthy volunteers and HIV-infected individuals were used for measurement of IL-1. Levels of IL-1 in the plasma samples were determined by ELISA using assay kits procured from eBioscience. Results in (b) are averages of data collected from eight healthy subjects and twelve individuals with HIV infection. Results show elevated IL-1 in HIV-infected subjects (*). (c) Assay of IL-17 in plasma from HIV-infected and healthy subjects. Plasma samples separated from blood of healthy volunteers and HIV-infected individuals were used for measurement of IL-17. Levels of IL-17 in the plasma samples were determined by ELISA using assay kits procured from eBioscience. Results in (c) are averages of data collected from eight healthy subjects and eight individuals with HIV infection. Results show elevated IL-17 in HIV-infected subjects (*).
